New Software for Analyzing Mass Spectra in Cancer Research
Author Information
Author(s): Mark K Titulaer, Ivar Siccama, Lennard J Dekker, Angelique L van Rijswijk, Ron M Heeren, Peter A Sillevis Smitt, Theo M Luider
Primary Institution: Erasmus MC
Hypothesis
Can a new database application effectively distinguish peptide profiles from patients and controls using mass spectrometry data?
Conclusion
The database application can distinguish MALDI-TOF peptide profiles between different patient and control groups using large datasets.
Supporting Evidence
- The software can analyze high throughput MS data efficiently.
- It generates a matrix with the frequency of peptide masses in replicate spectra.
- Statistical analysis using the Wilcoxon-Mann-Whitney test distinguishes peptide profiles.
Takeaway
This study created a new software that helps scientists compare protein data from cancer patients and healthy people quickly and easily.
Methodology
The software uses a Java GUI, a MySQL database for metadata, an FTP server for data storage, and R for statistical analysis, specifically the Wilcoxon-Mann-Whitney test.
Limitations
The software may struggle with very large datasets due to memory constraints.
Participant Demographics
The study involved breast cancer patients, prostate cancer patients, and control groups.
Statistical Information
P-Value
1.1 * 10^-6 to 9.8 * 10^-3
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website